Daniel P Fitzgerald

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

End Stage Renal Disease

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Kushal Prajapati, Chuan Yan, Qiqi Yang, Steven Arbitman, Daniel P Fitzgerald, Sasan Sharee, Jahangheer Shaik, Jason Bosiacki, Kayla V Myers Chen, Ana Paucarmayta, Dorothy M Johnson, Thomas O'Neill, Subhadip Kundu, Zachary Cusumano, Solomon Langermann, David M Langenau, Shashank Patel, Dallas B Flies
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies. Science advances 10 (9) (2024)
Kushal Prajapati, Chuan Yan, Qiqi Yang, Steven Arbitman, Daniel P Fitzgerald, Sasan Sharee, Jahangheer Shaik, Jason Bosiacki, Kayla V Myers Chen, Ana Paucarmayta, Dorothy M Johnson, Thomas O'Neill, Subhadip Kundu, Zachary Cusumano, Solomon Langermann, David M Langenau, Shashank Patel, Dallas B Flies
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies. Science advances 10 (9) (2024)
Kushal Prajapati, Chuan Yan, Qiqi Yang, Steven Arbitman, Daniel P Fitzgerald, Sasan Sharee, Jahangheer Shaik, Jason Bosiacki, Kayla V Myers Chen, Ana Paucarmayta, Dorothy M Johnson, Thomas O'Neill, Subhadip Kundu, Zachary Cusumano, Solomon Langermann, David M Langenau, Shashank Patel, Dallas B Flies
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies. Science advances 10 (9) (2024)